Arix Bioscience
plc
Notice of
Results
LONDON, 27 February 2020: Arix Bioscience plc (“Arix”
or the “Company”) (LSE: ARIX), a global venture capital company
focused on investing in and building breakthrough biotech
companies, will announce its annual results for the year ended
31 December 2019, on Tuesday
10 March 2020.
A presentation for analysts will be held on the same day at
12:15pm GMT in London and a webcast of the presentation will
be available on the Company's investor relations website at
https://arixbioscience.com/investor-relations/results-centre.
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
Charlotte Parry, Head of Investor
Relations
+44 (0) 20 7290 1072
charlotte@arixbioscience.com
Optimum Strategic Communications
Mary Clark, Supriya Mathur, Shabnam
Bashir
T: +44 (0) 20 3950 9144
optimum.arix@optimumcomms.com
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused
on investing in and building breakthrough biotech companies around
cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the
capital, expertise and global networks to help accelerate their
ideas into important new treatments for patients. As a listed
company, we are able to bring this exciting growth phase of our
industry to a broader range of investors.
www.arixbioscience.com